Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Ovarian Neoplasms 28Small Cell Lung Carcinoma 26Lung Neoplasms 20Neuroblastoma 17Carcinoma, Ovarian Epithelial 17Fallopian Tube Neoplasms 12Brain Neoplasms 10Uterine Cervical Neoplasms 8Sarcoma 8Leukemia 8Leukemia, Myeloid, Acute 6Central Nervous System Neoplasms 6Recurrence 5Medulloblastoma 5Lymphoma 5Gliosarcoma 5Glioblastoma 5Sarcoma, Ewing 4Rhabdoid Tumor 4Retinoblastoma 4Osteosarcoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Neoplasms 4Burkitt Lymphoma 4Wilms Tumor 3Neoplasm Metastasis 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Glioma 3

Interventions

Cyclophosphamide 23Cyclosporine 17Busulfan 16fludarabine phosphate 14Radiotherapy 12Mycophenolic Acid 12Cord Blood Stem Cell Transplantation 12Antilymphocyte Serum 12Peripheral Blood Stem Cell Transplantation 11Whole-Body Irradiation 10Methotrexate 8Methylprednisolone 7Tacrolimus 6Filgrastim 6Melphalan 5fludarabine 4sargramostim 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Cytarabine 3Cyclosporins 3merphos 2Transplantation 2Thiotepa 2Thalidomide 2Arsenic Trioxide 2vatalanib 1paricalcitol 1lintuzumab 1gamma-Globulins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anemia, Refractory × Topotecan × Clear all
NCT00003675 2016-07-20

Topotecan in Treating Patients With Myelodysplastic Syndrome

Alliance for Clinical Trials in Oncology

Phase 2 Completed
100 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡